EUVIMEDEUVIMED entdecken
Crossref

Disparities in lung cancer screening utilization at two health systems in the Southeastern USA

Soumya J Niranjan, Desiree Rivers, Rekha Ramachandran, JEdward Murrell, Kayleigh C Curry, Mohammed Mubasher, Eric Flenaugh, Mark T Dransfield, Sejong Bae, Isabel C Scarinci

Cancer Causes & Control · 2025

DOI: 10.1007/s10552-024-01929-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Causes & Control, 2025. Verfasst von Soumya J Niranjan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Services Administration, Birmingham, USA. Soumya14@uab.edu. Hauptthemen laut MEDLINE: Lung Neoplasms, Early Detection of Cancer, Healthcare Disparities. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: NIH HHS, National Institutes of Health, NCI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Low-dose computed tomography lung cancer screening is effective for reducing lung cancer mortality. It is critical to understand the lung cancer screening practices for screen-eligible individuals living in Alabama and Georgia where lung cancer is the leading cause of cancer death. High lung cancer incidence and mortality rates are attributed to high smoking rates among underserved, low income, and rural populations. Therefore, the purpose of this study is to define sociodemographic and clinical characteristics of patients who were screened for lung cancer at an Academic Medical Center (AMC) in Alabama and a Safety Net Hospital (SNH) in Georgia. METHODS: A retrospective cohort study of screen-eligible patients was constructed using electronic health records between 2015 and 2020 seen at an Academic Medical Center (AMC) and a Safety Net Hospital (SNH) separately. Chi-square tests and Student t tests were used to compare screening uptake across patient demographic and clinical variables. Bivariate and multivariate logistic regressions determined significant predictors of lung cancer screening uptake. RESULTS: At the AMC, 67,355 were identified as eligible for LCS and 1,129 were screened. In bivariate analyses, there were several differences between those who were screened and those who were not screened. Screening status in the site at Alabama-those with active tobacco use are significantly more likely to be screened than former smokers (OR: 3.208, p < 0.01). For every 10-unit increase in distance, the odds of screening decreased by about 15% (OR: 0.848, p < 0.01). For every 10-year increase in age, the odds of screening decrease by about 30% (OR: 0.704, p < 0.01). Each additional comorbidity increases the odds of screening by about 7.5% (OR: 1.075, p < 0.01). Those with both private and public insurance have much higher odds of screening compared to those with only private insurance (OR: 5.403, p < 0.01). However, those with only public insurance have lower odds of screening compared to those with private insurance (OR: 0.393, p < 0.01). At the SNH-each additional comorbidity increased the odds of screening by about 11.9% (OR: 1.119, p = 0.01). Notably, those with public insurance have significantly higher odds of being screened compared to those with private insurance (OR: 2.566, p < 0.01). CONCLUSION: The study provides evidence that LCS has not reached all subgroups and that additional targeted efforts are needed to increase lung cancer screening uptake. Furthermore, disparity was noticed between adults living closer to screening institutions and those who lived farther.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsEarly Detection of CancerHealthcare DisparitiesHumansFemaleMaleRetrospective StudiesMiddle AgedAgedAlabamaGeorgiaTomography, X-Ray ComputedMass Screening

Stichwörter der Autor:innen

Health equityLung cancer screeningRetrospective cohort study

Autor:innen und Institutionen

  • Department of Health Services Administration, Birmingham, USA. Soumya14@uab.edu.
  • Morehouse School of Medicine, Atlanta, USA.
  • Department of Health Services Administration, Birmingham, USA.

Förderung

  • NIH HHS
  • National Institutes of Health
  • NCI

Zitieren

APA

Niranjan, S. J., Rivers, D., Ramachandran, R., Murrell, J., Curry, K. C., Mubasher, M., Flenaugh, E., Dransfield, M. T., Bae, S., & Scarinci, I. C. (2025). Disparities in lung cancer screening utilization at two health systems in the Southeastern USA. Cancer Causes & Control. https://doi.org/10.1007/s10552-024-01929-6

Vancouver

Niranjan SJ, Rivers D, Ramachandran R, Murrell J, Curry KC, Mubasher M, et al. Disparities in lung cancer screening utilization at two health systems in the Southeastern USA. Cancer Causes & Control. 2025. doi:10.1007/s10552-024-01929-6

BibTeX
@article{Niranjan2025,
  author = {Niranjan, Soumya J and Rivers, Desiree and Ramachandran, Rekha and Murrell, JEdward and Curry, Kayleigh C and Mubasher, Mohammed and Flenaugh, Eric and Dransfield, Mark T and Bae, Sejong and Scarinci, Isabel C},
  title = {Disparities in lung cancer screening utilization at two health systems in the Southeastern USA},
  journal = {Cancer Causes & Control},
  year = {2025},
  doi = {10.1007/s10552-024-01929-6}
}
Kostenlos starten →